09.10.14
Slimaluma, a patented extract of Caralluma fimbriata offered by Gencor, Irvine, CA, has received notification from the Food and Drug Administration (FDA) of no objection to it being considered GRAS (Generally Recognized As Safe) for use in meal replacement products.
Gencor is offering Slimaluma for use as an ingredient in meal replacement products such as baked goods, bars, soups, drinks and shakes, at levels up to 350 milligrams per serving (700 milligrams per day). Slimaluma is currently in the market as an ingredient in dietary supplements and is effective in reducing waist circumference and suppressing appetite, when combined with healthy diet and exercise, according to Gencor.
On the basis of independent and collective critical evaluation of the available information on Slimaluma, an expert panel concluded that Slimaluma produced in accordance with current GMP standards and meeting specifications is safe for its intended use. Notification of this GRAS finding was filed with FDA without objection, and is designated GRN 500. AIBMR Life Sciences handled this project for Gencor.
Gencor is offering Slimaluma for use as an ingredient in meal replacement products such as baked goods, bars, soups, drinks and shakes, at levels up to 350 milligrams per serving (700 milligrams per day). Slimaluma is currently in the market as an ingredient in dietary supplements and is effective in reducing waist circumference and suppressing appetite, when combined with healthy diet and exercise, according to Gencor.
On the basis of independent and collective critical evaluation of the available information on Slimaluma, an expert panel concluded that Slimaluma produced in accordance with current GMP standards and meeting specifications is safe for its intended use. Notification of this GRAS finding was filed with FDA without objection, and is designated GRN 500. AIBMR Life Sciences handled this project for Gencor.
